A new examination of others who were discharged from the hospital after the covid-19 remedy found that four out of five were still reporting symptoms even 2 months later.
The research, in the Journal of the American Medical Association, evaluated 143 Italian patients who had been hospitalized by Covid-19 and who had survived.
On average, patients were evaluated two months after the onset of their first Covid-19 symptom and spent two weeks in the hospital recovering. 28 patients had gained invasive or noninvasive ventilation and to be included in the study, they had to be discharged from the hospital and tested negative for the virus. At the time of evaluation, none of the patients reported fever or any symptoms of acute Covid-19, but more than one part reported fatigue and 43% shortness of breath. Nearly a third of the survivors reported joint pain and 22% had chest pain.
Only 13% of patients had no relevant symptoms with Covid-19 after 2 months, while more from other people reported 3 or more symptoms. The test also asked patients a series of questions similar to their quality of life, with 44% of patients saying their quality of life was worse than before they were sick.
Covid-19 is thought to be a disease that severely affects only the elderly, however, the other people described in this test were between 19 and 84 years old, with an average age of 57.
It is worth noting that the test only evaluated other people who had been hospitalized by Covid-19, so the effects might not reflect other people who had a less severe Covid-19, who do not require hospitalization. In addition, nearly three-quarters of patients showed symptoms of interstitial pneumonia in the hospital and it is not for others to expand symptoms for several months after severe pneumonia, even if it is not caused by SARS-CoV2 coronavirus.
However, the new findings are becoming more and more evidence that in some other people, Covid-19 can cause persistent and lasting symptoms, even long after the virus itself can no longer be detected. Many doctors have warned that Covid-19 can lead to long-term disability in others with the disease and have asked for further studies on the acute and chronic effects of the virus.
Full coverage and live updates on the Coronavirus
I am a postdoctoral researcher specializing in cancers of formative years and new treatments for cancer. As a survivor of years of leukemia training, I am a
I am a postdoctoral researcher specializing in cancers of formative years and new targeted remedies for cancer. As a leukemia survivor in the formative years, I am a strong advocate for studies on better and less poisonous cancer remedies and how to decrease the long-term side effects of existing medications. I am an award-winning scientific communicator and have written for The Times, The Guardian and various cancer-focused media. I am also a TED 2017 fellow, having given my TED presentation on cancer survival and I give public lectures on topics ranging from “Why haven’t we cured cancer yet?” For “Cannabis and Cancer, exaggeration or hope?”. I am passionate about using social media to talk about science and calculus images and stories of my own real-time lab paintings on my Twitter account @vickyyyf, as well as comments on vital studies. Advances. You can receive more information about me and how to touch me through my online page drvickyforster.com. All my articles reflect my non-public comments and not those of my employer.